Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Nov 3, 1999
Current as of December 10, 2023
In order to carry out in vitro research procedures on the plasma or leukocyte components of blood, it is often necessary to obtain larger quantities of plasma and/or leukocytes, than can be safely obtained by simple phlebotomy. These components can be easily and safely obtained using apheresis procedures in the Clinical Center Apheresis Unit. This protocol is specifically designed to conform to the requirements of the Apheresis Unit for donors to have apheresis procedures (>7 years of age and greater than or equal to 25kg). Donors must first be admitted to another approved clinical research...
- INCLUSION CRITERIA:
- Enrolled on another LPD protocol.
- Weight greater than or equal to 25 kg
- Willingness to participate
- EXCLUSION CRITERIA:
- Age less than 7 years
- Weight less than 25 kg
- Cardiovascular instability
- Hct less than 30
- Inadequate venous access
- PTT or PT greater than 1.5 normal
- Women who are actively breastfeeding
- Other condition which the attending physician or Apheresis Unit staff considers a contraindication to the procedure
- For Hetastarch procedure
- Evidence of fluid retention
The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, United States
Ongoing as this is a method to collect cells from subjects enrolled on other LPD protocols
All reviews come from applied patients